| CGRGX | GWPDX | CGRGX / GWPDX | |
| Total Expense Ratio | 0.43 | 0.38 | 113% |
| Annual Report Gross Expense Ratio | 0.48 | 0.38 | 126% |
| Fund Existence | 5 years | 9 years | - |
| Gain YTD | 19.496 | 19.552 | 100% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 250 | 1000000 | 0% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 24.9B | 24.9B | 100% |
| Annual Yield % from dividends | 0.58 | 0.64 | 91% |
| Returns for 1 year | 10.55 | 10.63 | 99% |
| Returns for 3 years | 51.10 | 50.33 | 102% |
| Returns for 5 years | 36.16 | 34.57 | 105% |
| Returns for 10 years | N/A | N/A | - |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| NACP | 49.42 | 0.45 | +0.91% |
| Impact Shares NAACP Minority Empwrmt ETF | |||
| GDEC | 37.40 | 0.03 | +0.09% |
| FT Vest U.S. Eq Mod Buffr ETF - Dec | |||
| VNIE | 24.20 | N/A | N/A |
| Vontobel International Equity Active ETF | |||
| PSQO | 20.78 | -0.03 | -0.12% |
| Palmer Square Credit Opportunities ETF | |||
| ARKG | 29.76 | -0.09 | -0.30% |
| ARK Genomic Revolution ETF | |||